A Novel Tool to Predict the Overall Survival of High-Grade Osteosarcoma Patients after Neoadjuvant Chemotherapy: A Large Population-Based Cohort Study

Figure 3

ROC curves and AUC of nomograms for predicting OS at 3, 5, and 8 years in the training cohort (a). ROC curves and AUC of nomograms for predicting OS at 3, 5, and 8 years in the validation cohort (b). ROC, receiver operating characteristic; AUC, area under the curve; OS, overall survival.

(a)

(b)